Drug repurposing is no quick fix for developing new treatments for disease, including COVID-19, and there are inherent dangers and pitfalls with translating drugs such as chloroquine, hydroxychloroquine, ivermectin and similar compounds to treat COVID-19, say a team of experts. The potential challenges and opportunities with drug repurposing are highlighted in a paper authored by a cross-section […]
Read More… from Monash University: Drug repurposing is no panacea in race to treat COVID-19
WHO expert panel strongly advises against use of hydroxychloroquine to prevent covid-19: Drug is no longer a research priority; resources should focus on other more promising drugs to prevent covid-19. The anti-inflammatory drug hydroxychloroquine should not be used to prevent infection in people who do not have covid-19, say a WHO Guideline Development Group (GDG) […]
Read More… from Hydroxychloroquine: WHO expert panel strongly advises against use
Solidarity Therapeutics Trial produces conclusive evidence on the effectiveness of repurposed drugs for COVID-19 in record time In just six months, the world’s largest randomized control trial on COVID-19 therapeutics has generated conclusive evidence on the effectiveness of repurposed drugs for the treatment of COVID-19. Interim results from the Solidarity Therapeutics Trial, coordinated by the […]